Lowenstein Sandler and Davis Polk & Wardwell are advising Altair Engineering on the transaction. Siemens, a leading technology company focused on industry, infrastructure, mobility, and healthcare,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Netflix on the transaction, and Davis Polk & Wardwell advised the underwriters. Netflix, Inc. (Nasdaq: NFLX) completed its inaugural investment...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Paul Hastings advised GTCR on the transaction, and Davis Polk & Wardwell advised AssetMark. GTCR, a leading private equity firm with substantial...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised iRhythm Technologies, Inc. on the offering, and Davis Polk & Wardwell advised the initial purchasers. iRhythm Technologies, Inc. (Nasdaq: IRTC) announced its...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett advised Cisco Systems, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the underwriters. Cisco Systems, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Intel Corporation on the offering, and Davis Polk & Wardwell advised the joint book-running managers. Intel Corporation (Intel) (Nasdaq:INTC) announced its $2.55...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Xponential Fitness, as borrower, on the deal. Xponential Fitness, Inc. (NYSE: XPOF), as borrower, in connection with a $37 million incremental...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised Jefferies LLC, as sales agent. IDEAYA Biosciences, Inc. (NYSE: IDYA)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
You must be a Standard 1 Year member to access this content.
Cooley advised Olema Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised TD Cowen, as sales agent. Olema Pharmaceuticals ((“Olema”, Nasdaq: OLMA) announced its $150...
You must be a Standard 1 Year member to access this content.
